Rising Pharma Holding, Inc. recalls
3 recalls on record · FDA
Every recall we have on record for Rising Pharma Holding, Inc., compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.
Filter:
Health Serious
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only,…
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Rising Pharma Holding, Inc. Mar 11, 2026
Read the recall
Health Serious
Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only,…
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
Rising Pharma Holding, Inc. Oct 22, 2025
Read the recall
Health Serious
Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000…
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Rising Pharma Holding, Inc. Jan 15, 2025
Read the recall